Isolda Romero Canelon

Isolda Romero Canelon

Links

ORCID: 0000-0003-3847-4626

Colleges, School and Institutes

Willingness to take PhD students

Yes

View graph of relations

Most downloaded publications

Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action
Isolda Romero-Canelón, 13 Nov 2017, In : Metallomics.

Research output: Contribution to journal › Article

120 downloads
New activation mechanism for half-sandwich organometallic anticancer complexes
Isolda Romero-Canelón, 1 Mar 2018, In : Chemical Science. 9, 12, p. 3177-3185

Research output: Contribution to journal › Article

103 downloads
Designing ruthenium anticancer drugs: what have we learnt from the key drug candidates?
Isolda Romero-Canelón, 1 Mar 2019, In : Inorganics. 7, 3, 15 p., 31.

Research output: Contribution to journal › Review article

89 downloads
In vivo selectivity and localization of reactive oxygen species (ROS) induction by osmium anticancer complexes that circumvent platinum-resistance
Isolda Romero-Canelón, 25 Oct 2018, In : Journal of Medicinal Chemistry. 61, 20, p. 9246–9255

Research output: Contribution to journal › Article

88 downloads
Photoactivatable Cell-selective Dinuclear Trans Diazido Platinum(IV) Anticancer Prodrugs
Isolda Romero-Canelón, 26 Oct 2018, In : Journal of the American Chemical Society. 57, 22, p. 14409–14420 12 p.

Research output: Contribution to journal › Article

88 downloads

Recent publications

Lysyl Oxidase Like-2 (LOXL2): An Emerging Oncology Target
Isolda Romero-Canelón & Alan M Jones, 15 Jan 2020, In : Advanced Therapeutics.

Research output: Contribution to journal › Review article

Towards identification of essential structural elements of organoruthenium(II)-pyrithionato complexes for anticancer activity
Isolda Romero-Canelón, 7 Nov 2019, In : Chemistry: A European Journal. 25, 62, p. 14169-14182 14 p.

Research output: Contribution to journal › Article

Palladium (II) complexes with thiosemicarbazones derived from pyrene as topoisomerase IB inhibitors
Isolda Romero-Canelón, 30 Oct 2019, In : Dalton Transactions. 48, 44, p. 16509-16517 9 p.

Research output: Contribution to journal › Article

View all (50)

Recent Activities

Dalton Research Conference - Chemical modulation of cellular redox balance for cancer treatment
Isolda Romero-Canelón (Chair)
2018

Activity: Talk or presentation › Invited talk

Oncology Research Centre day - Precious metals in the fight against cancer
Isolda Romero-Canelón (Chair)
2018

Activity: Talk or presentation › Invited talk

Inorganic Chemistry Meets Medicine - Chemical modulation of cellular redox balance for cancer treatment
Isolda Romero-Canelón (Chair)
2017

Activity: Talk or presentation › Invited talk

View all (16)

Recent Prizes

Winner of exam and merit based admission process for tenure professorship

Isolda Romero-Canelón (Recipient), 2005

Prize: Appointment

RSC Dalton Division travel award

Isolda Romero-Canelón (Recipient), 2015

Prize: Prize (including medals and awards)

RSC Chemistry-Biology Interface Division travel award

Isolda Romero-Canelón (Recipient), 2014

Prize: Prize (including medals and awards)

View all (14)